Amprius Technologies, Inc.
Amprius develops, manufactures and markets lithium-ion batteries for mobility applications, including aviation, ground and marine vehicles. Its silicon anode technology replaces the graphite anode used in conventional lithium-ion batteries. Amprius sells batteries primarily for aviation applications such as drones and high-altitude pseudo satellites, and also serves other air transportation and light electric vehicle customers. Its products include SiCore batteries, commercially launched in January 2024, and SiMaxx batteries, which are in development. SiCore cells come in pouch, cylindrical and prismatic formats and are designed for high energy, high power or a balance of both. Amprius makes money by selling battery cells to customers inside and outside the United States, including aerospace, defense and other mobility companies. It produces SiCore batteries through agreements with global contract manufacturers and manufactures SiMaxx batteries at its Fremont facility. Amprius is headquartered in Fremont, California.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $AMPX in the last 30 days.
See all $AMPX insider activity →Amprius reported a Q3 net loss of $3.5M, with adjusted EBITDA at -$1M. The company maintained its full-year gross margin forecast of 28% and expects Q4 sales of $43.3M. Amprius is expanding manufacturing to meet demand, with a $75M contract for a U.S. battery production line. It also introduced new products for aviation and deep-sea applications, ending Q3 with $60.7M in cash.
Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights • Q3 2026 revenue increased 83% year-over-year to $39.1 million • Net loss of $3.5 million, a 10% year-over-year improvement • Increasing 2026 revenue outlook to $145 mil
Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.
Over the past 7 days, AlphAI's AI scored 11 news stories mentioning AMPX (Amprius Technologies, Inc.). Coverage has skewed bearish: 4 bullish, 2 neutral, and 5 bearish.
Recent AMPX coverage spans earnings, technology and financial news.
Earnings beat margin expectations and new defense contract could improve revenue visibility.
The strong quarterly performance and higher guidance suggest upside potential for the stock.
Upward pressure as the market prices in new defense funding and near‑term volume from the Caminus partnership.
Positive catalyst from analyst initiation and sizable defense grant.
The agreement expands Amprius' production capability and may improve revenue visibility, supporting a positive outlook for the stock.
AlphAI scores every news story that mentions AMPX with an AI model for sentiment and relevance, and aggregates insider trades from Amprius Technologies, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Amprius reported a Q3 net loss of $3.5M, with adjusted EBITDA at -$1M. The company maintained its full-year gross margin forecast of 28% and expects Q4 sales of $43.3M. Amprius is expanding manufacturing to meet demand, with a $75M contract for a U.S. battery production line. It also introduced new products for aviation and deep-sea applications, ending Q3 with $60.7M in cash.
Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights • Q3 2026 revenue increased 83% year-over-year to $39.1 million • Net loss of $3.5 million, a 10% year-over-year improvement • Increasing 2026 revenue outlook to $145 mil
Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.
Canaccord initiated coverage on Amprius Technologies (AMPX) with a Buy rating and $14 target, citing 144% revenue growth and market dominance. The company reported Q2 revenue of $34.02M, beating estimates, and raised full-year guidance. AMPX has a Strong Buy consensus with targets ranging from $18 to $30.
CAMINUS (formerly EnPower) has signed a contract manufacturing agreement with Amprius Technologies (NYSE: AMPX) to produce silicon-anode pouch cells at its Indianapolis facility. The deal covers partial assembly to full cell production, with volume production planned for 1Q27. Both companies emphasize the agreement's role in strengthening domestic battery supply chains for aviation, defense, and uncrewed systems.
Amprius (NYSE: AMPX) received a $75M grant from the U.S. Department of War to convert an EV battery line for high-energy density cells for drones. The $100M project, with a South Korean partner, aims to produce 12M cells annually by early 2028, meeting NDAA sourcing requirements.
Amprius Technologies (AMPX) shares rose 11% after receiving a $75M grant from the U.S. Department of War to convert a battery production line for unmanned aerial systems. The project, costing $100M, aims to produce 12M cells annually by early 2028, supporting NDAA-compliant domestic sourcing. The grant will expand Amprius' manufacturing capabilities in the U.S.
Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 23, 2026, Amprius Technologies, Inc. (the “Company”) entered into an Other Transaction Agreement (the “Agreement”) with the United States of America (the “U.S. Government”) for a project (“Project acCELLerate”) aw
Amprius Technologies (NYSE: AMPX) unveiled its second-gen SiCore battery, rated at 500 Wh/kg, for uncrewed electric aviation. The company claims it can be made with conventional lithium-ion manufacturing. Commercial availability is expected in Q4 2026. The tech may benefit high-altitude aircraft and drones, competing with SpaceX's Starlink satellites.
Amprius Technologies director Kang Sun sold 62,101 shares for $642,186 to cover tax obligations. The stock is down 4.2% this week. Amprius reported Q2 revenue of $34.02M, beating estimates, and raised its full-year revenue guidance to at least $140M. The company has $74.5M in cash and no debt.
